首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >FASTER (Face, Arm, Speech, Time, Emergency Response): experience of Central Coast Stroke Services implementation of a pre-hospital notification system for expedient management of acute stroke.
【24h】

FASTER (Face, Arm, Speech, Time, Emergency Response): experience of Central Coast Stroke Services implementation of a pre-hospital notification system for expedient management of acute stroke.

机译:更快(面部,手臂,言语,时间,紧急响应):中央海岸卒中服务部实施院前通知系统以快速管理急性卒中的经验。

获取原文
获取原文并翻译 | 示例
           

摘要

Despite benefit in acute ischaemic stroke, less than 3% of patients receive tissue plasminogen activator (tPA) in Australia. The FASTER (Face, Arm, Speech, Time, Emergency Response) protocol was constructed to reduce pre-hospital and Emergency Department (ED) delays and improve access to thrombolysis. This study aimed to determine if introduction of the FASTER protocol increases use of tPA using a prospective pre- and post-intervention cohort design in a metropolitan hospital. A pre-hospital assessment tool was used by ambulance services to screen potential tPA candidates. The acute stroke team was contacted, hospital bypass allowed, triage and CT radiology alerted, and the patient rapidly assessed on arrival to ED. Data were collected prospectively during the first 6 months of the new pathway and compared to a 6-month period 12 months prior to protocol initiation. In the 6 months following protocol introduction, 115 patients presented within 24 hours of onset of an ischaemic stroke: 22 (19%) received thrombolysis, significantly greater than five (7%) of 67 patients over the control period, p=0.03. Overall, 42 patients were referred via the FASTER pathway, with 21 of these receiving tPA (50%). One inpatient stroke was also treated. Only two referrals (<5%) were stroke mimics. Introduction of the FASTER pathway also significantly reduced time to thrombolysis and time to admission to the stroke unit. Therefore, fast-track referral of potential tPA patients involving the ambulance services and streamlined hospital assessment is effective and efficient in improving patient access to thrombolysis.
机译:尽管对急性缺血性卒中有益,但在澳大利亚,不到3%的患者接受组织纤溶酶原激活剂(tPA)。 FASTER(面部,手臂,言语,时间,紧急响应)协议旨在减少院前和急诊科(ED)的延误并改善溶栓治疗的机会。这项研究旨在确定采用FASTER方案是否可以在大城市医院中采用前瞻性干预前后的队列设计来增加tPA的使用。救护车服务使用院前评估工具筛选潜在的tPA候选人。联系了急性中风小组,允许绕过医院,进行了分诊和CT放射线检查,并在到达ED时迅速评估了患者。在新途径的前6个月中前瞻性地收集数据,并将其与方案启动前12个月的6个月期间进行比较。在引入方案后的6个月中,有115名患者在缺血性卒中发作后24小时内出现:22名(19%)接受了溶栓治疗,在对照期内明显超过67名患者中的5名(7%),p = 0.03。总体而言,通过FASTER途径转诊了42例患者,其中21例接受了tPA(50%)。还治疗了一名住院中风。仅两次转诊(<5%)是中风模拟。 FASTER途径的引入还显着减少了溶栓时间和中风单元入院时间。因此,涉及救护车服务和简化医院评估的潜在tPA患者的快速转诊在改善患者溶栓治疗方面是有效和高效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号